Search results
Inovio Pharma (INO) Stock Rallies 134% in a Month: Here's Why
Zacks via Yahoo Finance· 4 months agoInovio Pharma (INO) surges 134% in a month, mainly due to its plans to submit a regulatory...
INOVIA's (INO) Rare Disease Drug Gets EC's Orphan Tag, Stock Up
Zacks via Yahoo Finance· 1 year agoINOVIA (INO) shares surge 12% in the after-market hours, when its drug for treating a rare...
Does Inovio (INO) Have the Potential to Rally 122.92% as Wall Street Analysts Expect?
Zacks via Yahoo Finance· 3 months agoThe consensus price target hints at a 122.9% upside potential for Inovio (INO). While empirical...
Inovio Pharmaceuticals (INO) Q4 2023 Earnings Call Transcript
Motley Fool via Yahoo Finance· 3 months agoImage source: The Motley Fool. Inovio Pharmaceuticals (NASDAQ: INO) Q4 2023 Earnings Call Mar 06,...
This Under-the-Radar Stock Is Up by 96% This Year: Time to Buy?
Motley Fool via Yahoo Finance· 3 weeks agoSome investors might remember Inovio Pharmaceuticals (NASDAQ: INO); others might not. The small-cap...
Inovio Pharmaceuticals (INO) May Report Negative Earnings: Know the Trend Ahead of Next Week's...
Zacks via Yahoo Finance· 2 years agoInovio (INO) doesn't possess the right combination of the two key ingredients for a likely earnings...
Inovio Pharmaceuticals (NASDAQ:INO) adds US$37m to market cap in the past 7 days, though investors...
Simply Wall St. via Yahoo Finance· 1 year agoInovio Pharmaceuticals, Inc. (NASDAQ:INO) shareholders should be happy to see the share price up 11%...
Inovio Pharmaceuticals (INO) Reports Q1 Loss, Misses Revenue Estimates
Zacks via Yahoo Finance· 1 year agoInovio (INO) delivered earnings and revenue surprises of -14.29% and 42.50%, respectively, for the...
Better Buy: Inovio Pharmaceuticals vs. Novavax
Motley Fool via Yahoo Finance· 3 days agoThe COVID-19 vaccine was worth tens of billions of dollars, but most of it went into the hands of Moderna and Pfizer. Smaller biotechs that tried to...
Stock Market Plunge: 2 Stocks to Avoid Right Now
Motley Fool· 2 years agoIt's more important than ever to make highly selective investment decisions with a struggling stock market, challenging economic issues, and dangerous...